Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Ignatiadis"'
Autor:
Thierry Metens, Michael Ignatiadis, Marie Chintinne, Marc Lemort, Shih-Li Chao, Stylianos Drisis, Patrick Flamen
Publikováno v:
Journal of Magnetic Resonance Imaging. 48:982-993
BACKGROUND Validation of new biomarkers is essential for the early evaluation of neoadjuvant treatments. PURPOSE To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete respons
Autor:
Stylianos, Drisis, Patrick, Flamen, Michael, Ignatiadis, Thierry, Metens, Shih-Li, Chao, Marie, Chintinne, Marc, Lemort
Publikováno v:
Journal of magnetic resonance imaging : JMRI. 48(4)
Validation of new biomarkers is essential for the early evaluation of neoadjuvant treatments.To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete response (pCR) of neoadjuva
Autor:
Carsten Denkert, Sylvain Brohée, Michael Ignatiadis, Sherene Loi, Christos Sotiriou, Heikki Joensuu, Roberto Salgado, Sibylle Loibl, Martine Piccart, Amir Sonnenblick, Françoise Rothé, Nicolas Sirtaine, Debora Fumagalli, Patrick Neven, Christine Desmedt, Delphine Vincent
Publikováno v:
Oncotarget, 6 (30
Oncotarget
Oncotarget
Trastuzumab is a remarkably effective therapy for patients with human epidermal growth factor receptor 2 (HER2) - positive breast cancer (BC). However, not all women with high levels of HER2 benefit from trastuzumab. By integrating mRNA and protein e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c916f0534c3317a152e0727a774ec94b
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/227077
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/227077
Autor:
Evangelos Briasoulis, Vasilis Karavasilis, Lida Kostadima, Michael Ignatiadis, George Fountzilas, Nicholas Pavlidis
Publikováno v:
Cancer (0008543X); Oct2004, Vol. 101 Issue 7, p1524-1528, 5p